Prevalence characterization of extended-spectrum β-lactamases among Escherichia coli isolates collected in Zhengzhou

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 6, 2009, Pages 404-407

  Zhijian, Zhang ^a   Xiaobing, Guo ^b   Qinxian, Zhang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Escherichia coli; Extended spectrum lactamases (ESBLs); Prevalence; Zhengzhou

Indexed keywords

AGAR; BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENZYME ANALYSIS; ESCHERICHIA COLI; HEALTH CARE FACILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE;

BETA-LACTAMASES; CHINA; ELECTROPHORESIS, AGAR GEL; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI;

EID: 73249129447     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20351     Document Type: Article

References (23)

1. Katherine J, Wilson GLK, Phiri A, Corkill JE, French N, Hart CA. Identification and characterization of ceftriaxone resistance and extended-spectrum β-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother 2006;57:661-665.
2. Bonnet R, Dutour C, Sampaio JLM, et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 2001;45:2269-2275.
3. Cao V, Lambert T, Nhu DQ, et al. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002;46:3739-3743.
4. PER-1-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6′-N-acetyltransferase of type Ib. Antimicrob Agents Chemother 2003;47:697-703.
5. De Champs C, Poirel L, Bonnet R, et al. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 2002;46:3031-3034.
6. De Champs C, Sirot D, Chanal C, et al. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother 2002;44:3177-3179.
7. Gniadkowski M, Schneider I, Palucha A, et al. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: Identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998;42:827-832.
8. Vahaboglu H, Öztürk R, Aygün G, et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicentre study. Antimicrob Agents Chemother 1997;41:2265-2269.
9. Girlich D, Poirel L, Leelaporn A, et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001;l39:175-182.
10. De Champs C, Chanal C, Sirot D, et al. Frequency and diversity of class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: A 2 year prospective study. J Antimicrob Chemother 2004;54:634-639.
11. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001;32:S94-S103.
12. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004;54:735-743.
13. Yu WL, Chuang YC, Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: Epidemiology, detection, treatment, and infection control. J Microbiol Immunol Infect 2006;39:264-277.
14. Bonnet R. Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
15. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-475.
16. Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Ben Redjeb S. Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 2006;50:2433-2438.
17. Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14:413-414.
18. Naas T, Lezzar A, Bentchouala C, Smati F, Scheftel JM,Monteil H. Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M β-lactamases from Constantine, Algeria. J Antimicrob Chemother 2005;56:439-440.
19. Messai Y, Benhassine B, Naim M, Paul G, Bakour R. Prevalence of betalactams resistance among Escherichia coli clinical isolates from a hospital in Algiers. Rev Esp Quimioter 2006;19:144-151.
20. Ramdani-Bouguessa N, Mendonc-a N, Leitão J, Ferreira E, Tazir M, Canic-aM. CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 2006;44:4584-4586.
21. Touati A, Benallaoua S, Forte D, Madoux J, Brasme L, de Champs C. First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria. Int J Antimicrob Agents 2006;27:397-402.
22. Iabadene H, Messai Y, Ammari H, et al. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 2008;62:133-136.
23. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, et al. Emergence and outbreaks of CTX-M β-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006;44:4049-4056.